Dogsee Chew, India’s fastest-growing natural pet treat business, has secured Rs 50 crore in a Series A investment led by Mankind Pharma and Sixth Sense Ventures.
This is Mankind Pharma’s first foray into the pet food market. Sixth Sense Ventures had previously invested in the company’s pre-series A investment round, which took place in November 2021.
Talking about the investment, Dogsee Chew founder Bhupendra Khanal said, “Our products are the result of years of careful research focused on the precise nutritional needs of dogs. We put research and innovation at the heart of everything we do. The more we understand, the better placed we are to make a positive difference to the health and well-being of pets. Mankind pharma has an established history of creating highly successful consumer products. Having the backing of such a giant is a huge vote of confidence for us and we look forward to learning from their expertise.”
Sneh Sharma, Dogsee Chew co-founder mentioned, ”With Mankind, we share the common DNA of innovation. We are confident that with their support, we will be able to develop the niche that we have envisioned for the brand.” She also added, “Sixth Sense Ventures has been a great partner for us. We are excited to be deepening our partnership with this round. It speaks a lot about the trust and comfort we have established between us in such a short span of time.”
The funds will be used largely for brand development, research and development, and the establishment of a robust distribution network.
Speaking of their investment in Dogsee Chew, Mr Arjun Juneja Chief Operations Officer of Mankind Pharma said, ”The trust that people have shown in Dogsee Chew has strengthened our confidence to invest in a brand that is true to its nature. Mankind has always believed in innovation and, with brands like Dogsee Chew that are innovative & young, we see the future of India.”
